spinal cord

Fungal Meningitis Outbreak Victims Still Suffer Lingering Illness

By | Thu, 10/24/2013 - 20:04

The consequences of a fungal outbreak that peaked last fall still linger for those who took a tainted steroid injection.


New Boss of Meningitis-Linked Firm Is Poor Choice: U.S. Official

By | Tue, 01/08/2013 - 12:26

The person hired to run the bankrupt pharmacy linked to a deadly U.S. meningitis outbreak is "hopelessly conflicted" and should be removed from the job, a U.S. Justice Department official said.

fungal meningitis specimen

House Republicans to FDA: No Meningitis Action Without Documents

By | Mon, 11/19/2012 - 16:56

Republicans on a congressional panel investigating a deadly meningitis outbreak told FDA not to expect new authority to prevent future problems until the agency hands over documents about its role in the current crisis.

Affiliate of Meningitis-linked Firm Initiates Mass Layoffs

By | Fri, 11/09/2012 - 11:30

Ameridose LLC, an affiliate of NECC at the heart of the deadly U.S. meningitis outbreak, is laying off about 90 percent of its workforce.


Meningitis-Linked Massachusetts Pharmacy Fires Director

By | Thu, 11/08/2012 - 11:22

The director of NECC was fired because he had ignored a complaint lodged against the company in July.

fungal meningitis specimen

Bacteria Found in Drugs From Company Linked to Meningitis Outbreak

By | Fri, 11/02/2012 - 10:11

Bacteria were found in the recent recalled products of the New England Compounding Center that has been associated with the recent meningitis outbreak.


FDA: Meningitis-Linked Pharmacy Knew of Contaminants for Months, Did Nothing

By | Mon, 10/29/2012 - 12:15

Staffers at the New England Compounding Center knew of contamination in the pharmacy for months, but chose to do nothing.

FDA Finds Contaminants in Drug Linked to Meningitis

By | Sat, 10/27/2012 - 11:48

The FDA said it found "greenish black foreign matter" and other contaminants in an injectable steroid produced by the New England Compounding Center.


Red Flags Ignored for Years at Firm in Meningitis Crisis

By | Sat, 10/27/2012 - 11:31

Interviews with former NECC employees and a review of internal documents and state records show how regulators failed to punish the company despite repeated violations of the rules.

Meningitis Suits May Turn on How Injections Are Defined

By | Wed, 10/24/2012 - 11:39

Victims of a deadly U.S. meningitis outbreak are starting to sue the physicians and clinics that administered tainted steroid shots, and the success of the suits could hinge on whether judges decide the injections are subject to product liability or medical malpractice laws.

Meningitis Probe Could Hit Hospital Drug Supplies

By | Tue, 10/23/2012 - 11:02

The extended shutdown of a sister company of the pharmacy at the center of the deadly U.S. meningitis outbreak may exacerbate drug shortages for some hospitals and healthcare providers.

necc meningitis

Before U.S. Meningitis Outbreak, NECC Avoided Sanctions Several Times

By | Tue, 10/23/2012 - 10:54

The pharmacy tied to a deadly U.S. meningitis outbreak escaped harsh punishment from health regulators several times that has raised questions about oversight of the customized drug mixing industry.

fungal meningitis, sample of Cladosporium species

Health Officials Knew of Problem Steroids in 2002: U.S. House Panel

By | Tue, 10/23/2012 - 09:05

U.S. and Massachusetts state health regulators were aware in 2002 that steroid treatments from the pharmacy at the center of a deadly meningitis outbreak could cause adverse patient reactions.

Meningitis Toll Rises to 21; Pharmacy Owners Sued

By | Sat, 10/20/2012 - 10:20

Executives at the Boston-area pharmacy whose steroid shots have been linked to a deadly U.S. meningitis outbreak have been sued in a bid to freeze their personal assets.

fungal meningitis specimen

In U.S. Meningitis Scare, States Face Huge Task of Tracking Drugs

By | Sat, 10/20/2012 - 10:06

The list of NECC products fills 70 pages. The FDA specifically advised doctors to alert patients who received injected NECC drugs during heart and eye surgeries that the company produced after May 21.